Lixisenatide Treatment for Older Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetics: Meta-Analysis of Five Randomized Controlled Trials View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-08

AUTHORS

Markolf Hanefeld, Rachele Berria, Jay Lin, Ronnie Aronson, Patrice Darmon, Marc Evans, Luc Van Gaal

ABSTRACT

AIM: Evaluate the efficacy and safety of lixisenatide, a once-daily prandial glucagon-like peptide-1 receptor agonist, in older patients with type 2 diabetes mellitus (T2DM) insufficiently controlled on oral antidiabetics (OADs). METHODS: A meta-analysis was conducted on data from older patients (≥65 years) from five of the GetGoal trials, in which patients with T2DM were treated with lixisenatide 20 µg once daily or placebo, as an add-on to OADs. The primary endpoint in all trials was change from baseline at week 24 in glycated hemoglobin (HbA1c). Other endpoints included changes in post-prandial plasma glucose (PPG), fasting plasma glucose (FPG) and weight. Composite and safety endpoints were also analyzed. RESULTS: A total of 501 patients aged ≥65 years were included in this meta-analysis: 304 received lixisenatide plus OADs and 197 received placebo as add-on to OADs. Lixisenatide as an add-on to OADs significantly reduced HbA1c, PPG, FPG and weight, with placebo-corrected treatment effects at week 24 of -0.54% (p<0.0001), -126 mg/dL (p<0.0001), -13 mg/dL (p=0.0005) and -0.90 kg (p=0.0021), respectively. Patients receiving lixisenatide plus OADs were significantly more likely to achieve composite (HbA1c levels<7%, HbA1c levels<7% and no symptomatic hypoglycemia, and HbA1c levels<7%, no weight gain and no symptomatic hypoglycemia) and safety endpoints than those receiving placebo plus OADs. Symptomatic hypoglycemia was experienced by 8.55% and 3.55% of patients in the lixisenatide plus OADs and placebo plus OADs groups, respectively (p=0.0276), although no serious hypoglycemic episodes were reported. CONCLUSIONS: Lixisenatide plus OADs improved glycemic control in older patients inadequately controlled on OADs compared with placebo plus OADs. Lixisenatide is well tailored to the pathophysiology of T2DM in older patients. More... »

PAGES

861-872

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12325-014-0146-4

DOI

http://dx.doi.org/10.1007/s12325-014-0146-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051264420

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25143188


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postprandial Period", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "TU Dresden", 
          "id": "https://www.grid.ac/institutes/grid.4488.0", 
          "name": [
            "GWT-TUD, Study Centre Prof. Hanefeld, Dresden Technical University, Fiedlerstr. 34, 01307, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hanefeld", 
        "givenName": "Markolf", 
        "id": "sg:person.01256767110.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256767110.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417555.7", 
          "name": [
            "Sanofi, Bridgewater, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berria", 
        "givenName": "Rachele", 
        "id": "sg:person.0711665445.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711665445.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Novosys Health, Flemington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Jay", 
        "id": "sg:person.0660000024.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660000024.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "LMC Diabetes & Endocrinology (Canada)", 
          "id": "https://www.grid.ac/institutes/grid.492821.4", 
          "name": [
            "LMC Diabetes and Endocrinology, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aronson", 
        "givenName": "Ronnie", 
        "id": "sg:person.0613700576.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613700576.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marseille Public University Hospital System", 
          "id": "https://www.grid.ac/institutes/grid.414336.7", 
          "name": [
            "Sainte-Marguerite University Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Darmon", 
        "givenName": "Patrice", 
        "id": "sg:person.0610536152.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610536152.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiff and Vale University Health Board", 
          "id": "https://www.grid.ac/institutes/grid.273109.e", 
          "name": [
            "University Hospital Llandough, Llandough, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "Marc", 
        "id": "sg:person.01167546340.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Antwerp University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411414.5", 
          "name": [
            "Antwerp University Hospital, Edegem-Antwerp, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Van Gaal", 
        "givenName": "Luc", 
        "id": "sg:person.01247356256.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247356256.99"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2337/dc11-s207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001994299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje-08-0596", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002314512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2454", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002457907"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004232638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.23.9.1272", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006261908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.28.5.1092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007868854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dme.12328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009392985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2012.01618.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010490185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db05-1672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011203470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4158/ep13176.cs", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011456704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4158/ep13176.cs", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011456704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrendo.2012.140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011731640", 
          "https://doi.org/10.1038/nrendo.2012.140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc08-1171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013179967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc11-1935", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013652554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-0413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013892720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00579707", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014785403", 
          "https://doi.org/10.1007/bf00579707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2009.460", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016104743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/dmrr.2588", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018207053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.165.14.1612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019577366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjopharm.2011.09.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023975637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.hep.2003.08.052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024327878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-s011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026975709"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2462", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026984704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/dmrr.2541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029422308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1755-5922.12000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030263972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007995.2012.686901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031345775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1445-5994.2012.02758.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038187876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.numecd.2006.05.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040738163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc13-0520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042419212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1152/physrev.00034.2006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045521074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047099632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(91)80085-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047206679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2014.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047234672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jgp.0b013e31823038db", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047627850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000120505.91348.58", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049845158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050389695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926721", 
          "https://doi.org/10.1007/s001250050617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926721", 
          "https://doi.org/10.1007/s001250050617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.52.1.102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052696912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.28.5.1083", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053076188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0195-668x(03)00468-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054625466"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ageing/22.1.37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059368991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/me.2006-0056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064327693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.17925/ee.2013.09.02.76", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068543190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/aging.100350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068670668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5414/cp201361", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072833982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-154-2-201101180-00300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073712032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajcn/82.5.923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077139593"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08", 
    "datePublishedReg": "2014-08-01", 
    "description": "AIM: Evaluate the efficacy and safety of lixisenatide, a once-daily prandial glucagon-like peptide-1 receptor agonist, in older patients with type 2 diabetes mellitus (T2DM) insufficiently controlled on oral antidiabetics (OADs).\nMETHODS: A meta-analysis was conducted on data from older patients (\u226565 years) from five of the GetGoal trials, in which patients with T2DM were treated with lixisenatide 20 \u00b5g once daily or placebo, as an add-on to OADs. The primary endpoint in all trials was change from baseline at week 24 in glycated hemoglobin (HbA1c). Other endpoints included changes in post-prandial plasma glucose (PPG), fasting plasma glucose (FPG) and weight. Composite and safety endpoints were also analyzed.\nRESULTS: A total of 501 patients aged \u226565 years were included in this meta-analysis: 304 received lixisenatide plus OADs and 197 received placebo as add-on to OADs. Lixisenatide as an add-on to OADs significantly reduced HbA1c, PPG, FPG and weight, with placebo-corrected treatment effects at week 24 of -0.54% (p<0.0001), -126 mg/dL (p<0.0001), -13 mg/dL (p=0.0005) and -0.90 kg (p=0.0021), respectively. Patients receiving lixisenatide plus OADs were significantly more likely to achieve composite (HbA1c levels<7%, HbA1c levels<7% and no symptomatic hypoglycemia, and HbA1c levels<7%, no weight gain and no symptomatic hypoglycemia) and safety endpoints than those receiving placebo plus OADs. Symptomatic hypoglycemia was experienced by 8.55% and 3.55% of patients in the lixisenatide plus OADs and placebo plus OADs groups, respectively (p=0.0276), although no serious hypoglycemic episodes were reported.\nCONCLUSIONS: Lixisenatide plus OADs improved glycemic control in older patients inadequately controlled on OADs compared with placebo plus OADs. Lixisenatide is well tailored to the pathophysiology of T2DM in older patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12325-014-0146-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096634", 
        "issn": [
          "0741-238X", 
          "1865-8652"
        ], 
        "name": "Advances in Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Lixisenatide Treatment for Older Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetics: Meta-Analysis of Five Randomized Controlled Trials", 
    "pagination": "861-872", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f433e1b49aeb63dbc1e393f0b781bf901e20443a9496f0529417333558db022d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25143188"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8611864"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12325-014-0146-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051264420"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12325-014-0146-4", 
      "https://app.dimensions.ai/details/publication/pub.1051264420"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12325-014-0146-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12325-014-0146-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12325-014-0146-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12325-014-0146-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12325-014-0146-4'


 

This table displays all metadata directly associated to this object as RDF triples.

333 TRIPLES      21 PREDICATES      91 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12325-014-0146-4 schema:about N20787f90446f4832b0e0390656f3d1fe
2 N4cda0cdb5d564c06913ffc133436b8c6
3 N580df1c5d22e46b29f8011e0af016292
4 N60a470ff8e4f4140ae7664af593e54bd
5 N65bce04d8fa747bd8ec88907782e59f1
6 N676a245b5c85473998575b7225545f7a
7 N680e3b73511e4ddfa4603d9548a2be5b
8 N70ca9aa296c64a8d854d70db33ec02f8
9 N7114c0ee77f84b4fb442c87dea7f4722
10 N8700a4d076404f46b5a558892bb5cdfd
11 N9de74439daa5435d81f481cf403ec1fe
12 Na1e58e0c3d5641a18ba065158835f1e2
13 Ne7600b1dea55414e95149a2d8b4f3097
14 Nea95e0b8ee87411eb9ced1be820db1ce
15 Nee8f8ed12bf74c8888353cede4606723
16 Nf5c58d980c164bffa7b75fb1f47b4708
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N0309265f362449dea1da2c567550ec24
20 schema:citation sg:pub.10.1007/bf00579707
21 sg:pub.10.1007/s001250050617
22 sg:pub.10.1038/nrendo.2012.140
23 https://doi.org/10.1001/archinte.165.14.1612
24 https://doi.org/10.1001/jama.2009.460
25 https://doi.org/10.1002/dmrr.2541
26 https://doi.org/10.1002/dmrr.2588
27 https://doi.org/10.1016/0002-9343(91)80085-z
28 https://doi.org/10.1016/j.amjopharm.2011.09.007
29 https://doi.org/10.1016/j.hep.2003.08.052
30 https://doi.org/10.1016/j.jdiacomp.2014.01.012
31 https://doi.org/10.1016/j.numecd.2006.05.006
32 https://doi.org/10.1016/s0195-668x(03)00468-8
33 https://doi.org/10.1093/ageing/22.1.37
34 https://doi.org/10.1093/ajcn/82.5.923
35 https://doi.org/10.1097/jgp.0b013e31823038db
36 https://doi.org/10.1111/1755-5922.12000
37 https://doi.org/10.1111/dme.12328
38 https://doi.org/10.1111/dom.12121
39 https://doi.org/10.1111/j.1445-5994.2012.02758.x
40 https://doi.org/10.1111/j.1463-1326.2012.01618.x
41 https://doi.org/10.1152/physrev.00034.2006
42 https://doi.org/10.1161/01.cir.0000120505.91348.58
43 https://doi.org/10.1185/03007995.2012.686901
44 https://doi.org/10.1210/me.2006-0056
45 https://doi.org/10.1530/eje-08-0596
46 https://doi.org/10.17925/ee.2013.09.02.76
47 https://doi.org/10.18632/aging.100350
48 https://doi.org/10.2337/db05-1672
49 https://doi.org/10.2337/dc08-1171
50 https://doi.org/10.2337/dc11-1935
51 https://doi.org/10.2337/dc11-s207
52 https://doi.org/10.2337/dc12-0413
53 https://doi.org/10.2337/dc12-2006
54 https://doi.org/10.2337/dc12-2454
55 https://doi.org/10.2337/dc12-2462
56 https://doi.org/10.2337/dc12-2709
57 https://doi.org/10.2337/dc12-s011
58 https://doi.org/10.2337/dc13-0520
59 https://doi.org/10.2337/diabetes.52.1.102
60 https://doi.org/10.2337/diacare.23.9.1272
61 https://doi.org/10.2337/diacare.28.5.1083
62 https://doi.org/10.2337/diacare.28.5.1092
63 https://doi.org/10.4158/ep13176.cs
64 https://doi.org/10.5414/cp201361
65 https://doi.org/10.7326/0003-4819-154-2-201101180-00300
66 schema:datePublished 2014-08
67 schema:datePublishedReg 2014-08-01
68 schema:description AIM: Evaluate the efficacy and safety of lixisenatide, a once-daily prandial glucagon-like peptide-1 receptor agonist, in older patients with type 2 diabetes mellitus (T2DM) insufficiently controlled on oral antidiabetics (OADs). METHODS: A meta-analysis was conducted on data from older patients (≥65 years) from five of the GetGoal trials, in which patients with T2DM were treated with lixisenatide 20 µg once daily or placebo, as an add-on to OADs. The primary endpoint in all trials was change from baseline at week 24 in glycated hemoglobin (HbA1c). Other endpoints included changes in post-prandial plasma glucose (PPG), fasting plasma glucose (FPG) and weight. Composite and safety endpoints were also analyzed. RESULTS: A total of 501 patients aged ≥65 years were included in this meta-analysis: 304 received lixisenatide plus OADs and 197 received placebo as add-on to OADs. Lixisenatide as an add-on to OADs significantly reduced HbA1c, PPG, FPG and weight, with placebo-corrected treatment effects at week 24 of -0.54% (p<0.0001), -126 mg/dL (p<0.0001), -13 mg/dL (p=0.0005) and -0.90 kg (p=0.0021), respectively. Patients receiving lixisenatide plus OADs were significantly more likely to achieve composite (HbA1c levels<7%, HbA1c levels<7% and no symptomatic hypoglycemia, and HbA1c levels<7%, no weight gain and no symptomatic hypoglycemia) and safety endpoints than those receiving placebo plus OADs. Symptomatic hypoglycemia was experienced by 8.55% and 3.55% of patients in the lixisenatide plus OADs and placebo plus OADs groups, respectively (p=0.0276), although no serious hypoglycemic episodes were reported. CONCLUSIONS: Lixisenatide plus OADs improved glycemic control in older patients inadequately controlled on OADs compared with placebo plus OADs. Lixisenatide is well tailored to the pathophysiology of T2DM in older patients.
69 schema:genre research_article
70 schema:inLanguage en
71 schema:isAccessibleForFree false
72 schema:isPartOf N115af56d1db14c7cb34370ee0374190e
73 Nfc67d0635dda454fabcffae4ad15f43f
74 sg:journal.1096634
75 schema:name Lixisenatide Treatment for Older Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetics: Meta-Analysis of Five Randomized Controlled Trials
76 schema:pagination 861-872
77 schema:productId N269b0f2432384aae9b31c1280a50fac4
78 Na40fdd2b163d4194bab767d58c1d7b9b
79 Na940a47927aa4fe38328801ca428609f
80 Nd51e5b6e88514ae6a235cb4a179bce3d
81 Ne71c1f87c8564fcba3d0f1d9b45bd69a
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051264420
83 https://doi.org/10.1007/s12325-014-0146-4
84 schema:sdDatePublished 2019-04-10T15:54
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Nd44e9bbd243e4b359ff895b4f3337465
87 schema:url http://link.springer.com/10.1007%2Fs12325-014-0146-4
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N02ab636394004000ad9e2cdaa91b8dc1 rdf:first sg:person.0610536152.18
92 rdf:rest Nec86b09872a54e89aa65e16de187219c
93 N0309265f362449dea1da2c567550ec24 rdf:first sg:person.01256767110.97
94 rdf:rest N56a2c2f18bba442aad6e1714a9ffac2c
95 N115af56d1db14c7cb34370ee0374190e schema:issueNumber 8
96 rdf:type schema:PublicationIssue
97 N20787f90446f4832b0e0390656f3d1fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Body Weight
99 rdf:type schema:DefinedTerm
100 N269b0f2432384aae9b31c1280a50fac4 schema:name readcube_id
101 schema:value f433e1b49aeb63dbc1e393f0b781bf901e20443a9496f0529417333558db022d
102 rdf:type schema:PropertyValue
103 N4cda0cdb5d564c06913ffc133436b8c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Humans
105 rdf:type schema:DefinedTerm
106 N56a2c2f18bba442aad6e1714a9ffac2c rdf:first sg:person.0711665445.31
107 rdf:rest Nc7b6bbea2e73418b972fbd12b3a68d22
108 N580df1c5d22e46b29f8011e0af016292 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Blood Glucose
110 rdf:type schema:DefinedTerm
111 N5d45268eb68d409bac480e7bff38edf3 rdf:first sg:person.01247356256.99
112 rdf:rest rdf:nil
113 N60a470ff8e4f4140ae7664af593e54bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Postprandial Period
115 rdf:type schema:DefinedTerm
116 N65bce04d8fa747bd8ec88907782e59f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Hypoglycemia
118 rdf:type schema:DefinedTerm
119 N676a245b5c85473998575b7225545f7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Aged
121 rdf:type schema:DefinedTerm
122 N680e3b73511e4ddfa4603d9548a2be5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hypoglycemic Agents
124 rdf:type schema:DefinedTerm
125 N70ca9aa296c64a8d854d70db33ec02f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Diabetes Mellitus, Type 2
127 rdf:type schema:DefinedTerm
128 N7114c0ee77f84b4fb442c87dea7f4722 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Male
130 rdf:type schema:DefinedTerm
131 N8700a4d076404f46b5a558892bb5cdfd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Drug Therapy, Combination
133 rdf:type schema:DefinedTerm
134 N9de74439daa5435d81f481cf403ec1fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Randomized Controlled Trials as Topic
136 rdf:type schema:DefinedTerm
137 Na1e58e0c3d5641a18ba065158835f1e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Drug Administration Schedule
139 rdf:type schema:DefinedTerm
140 Na40fdd2b163d4194bab767d58c1d7b9b schema:name dimensions_id
141 schema:value pub.1051264420
142 rdf:type schema:PropertyValue
143 Na940a47927aa4fe38328801ca428609f schema:name doi
144 schema:value 10.1007/s12325-014-0146-4
145 rdf:type schema:PropertyValue
146 Nc7b6bbea2e73418b972fbd12b3a68d22 rdf:first sg:person.0660000024.36
147 rdf:rest Ndf742a0e1a8541d49c42e4d81226b6e5
148 Nd3530077d5fe4e29b1b7d0adbe8c93d0 schema:name Novosys Health, Flemington, NJ, USA
149 rdf:type schema:Organization
150 Nd44e9bbd243e4b359ff895b4f3337465 schema:name Springer Nature - SN SciGraph project
151 rdf:type schema:Organization
152 Nd51e5b6e88514ae6a235cb4a179bce3d schema:name nlm_unique_id
153 schema:value 8611864
154 rdf:type schema:PropertyValue
155 Ndf742a0e1a8541d49c42e4d81226b6e5 rdf:first sg:person.0613700576.63
156 rdf:rest N02ab636394004000ad9e2cdaa91b8dc1
157 Ne71c1f87c8564fcba3d0f1d9b45bd69a schema:name pubmed_id
158 schema:value 25143188
159 rdf:type schema:PropertyValue
160 Ne7600b1dea55414e95149a2d8b4f3097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Female
162 rdf:type schema:DefinedTerm
163 Nea95e0b8ee87411eb9ced1be820db1ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Glycated Hemoglobin A
165 rdf:type schema:DefinedTerm
166 Nec86b09872a54e89aa65e16de187219c rdf:first sg:person.01167546340.80
167 rdf:rest N5d45268eb68d409bac480e7bff38edf3
168 Nee8f8ed12bf74c8888353cede4606723 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Double-Blind Method
170 rdf:type schema:DefinedTerm
171 Nf5c58d980c164bffa7b75fb1f47b4708 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Peptides
173 rdf:type schema:DefinedTerm
174 Nfc67d0635dda454fabcffae4ad15f43f schema:volumeNumber 31
175 rdf:type schema:PublicationVolume
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
180 schema:name Clinical Sciences
181 rdf:type schema:DefinedTerm
182 sg:journal.1096634 schema:issn 0741-238X
183 1865-8652
184 schema:name Advances in Therapy
185 rdf:type schema:Periodical
186 sg:person.01167546340.80 schema:affiliation https://www.grid.ac/institutes/grid.273109.e
187 schema:familyName Evans
188 schema:givenName Marc
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80
190 rdf:type schema:Person
191 sg:person.01247356256.99 schema:affiliation https://www.grid.ac/institutes/grid.411414.5
192 schema:familyName Van Gaal
193 schema:givenName Luc
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247356256.99
195 rdf:type schema:Person
196 sg:person.01256767110.97 schema:affiliation https://www.grid.ac/institutes/grid.4488.0
197 schema:familyName Hanefeld
198 schema:givenName Markolf
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256767110.97
200 rdf:type schema:Person
201 sg:person.0610536152.18 schema:affiliation https://www.grid.ac/institutes/grid.414336.7
202 schema:familyName Darmon
203 schema:givenName Patrice
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610536152.18
205 rdf:type schema:Person
206 sg:person.0613700576.63 schema:affiliation https://www.grid.ac/institutes/grid.492821.4
207 schema:familyName Aronson
208 schema:givenName Ronnie
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613700576.63
210 rdf:type schema:Person
211 sg:person.0660000024.36 schema:affiliation Nd3530077d5fe4e29b1b7d0adbe8c93d0
212 schema:familyName Lin
213 schema:givenName Jay
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660000024.36
215 rdf:type schema:Person
216 sg:person.0711665445.31 schema:affiliation https://www.grid.ac/institutes/grid.417555.7
217 schema:familyName Berria
218 schema:givenName Rachele
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711665445.31
220 rdf:type schema:Person
221 sg:pub.10.1007/bf00579707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014785403
222 https://doi.org/10.1007/bf00579707
223 rdf:type schema:CreativeWork
224 sg:pub.10.1007/s001250050617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050926721
225 https://doi.org/10.1007/s001250050617
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/nrendo.2012.140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011731640
228 https://doi.org/10.1038/nrendo.2012.140
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1001/archinte.165.14.1612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019577366
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1001/jama.2009.460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016104743
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1002/dmrr.2541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029422308
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1002/dmrr.2588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018207053
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/0002-9343(91)80085-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1047206679
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.amjopharm.2011.09.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023975637
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.hep.2003.08.052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024327878
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.jdiacomp.2014.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047234672
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.numecd.2006.05.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040738163
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/s0195-668x(03)00468-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054625466
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1093/ageing/22.1.37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059368991
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1093/ajcn/82.5.923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077139593
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1097/jgp.0b013e31823038db schema:sameAs https://app.dimensions.ai/details/publication/pub.1047627850
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1111/1755-5922.12000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030263972
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1111/dme.12328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009392985
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/dom.12121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047099632
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1111/j.1445-5994.2012.02758.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038187876
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1111/j.1463-1326.2012.01618.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010490185
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1152/physrev.00034.2006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045521074
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1161/01.cir.0000120505.91348.58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049845158
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1185/03007995.2012.686901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031345775
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1210/me.2006-0056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064327693
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1530/eje-08-0596 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002314512
275 rdf:type schema:CreativeWork
276 https://doi.org/10.17925/ee.2013.09.02.76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068543190
277 rdf:type schema:CreativeWork
278 https://doi.org/10.18632/aging.100350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068670668
279 rdf:type schema:CreativeWork
280 https://doi.org/10.2337/db05-1672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011203470
281 rdf:type schema:CreativeWork
282 https://doi.org/10.2337/dc08-1171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013179967
283 rdf:type schema:CreativeWork
284 https://doi.org/10.2337/dc11-1935 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013652554
285 rdf:type schema:CreativeWork
286 https://doi.org/10.2337/dc11-s207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001994299
287 rdf:type schema:CreativeWork
288 https://doi.org/10.2337/dc12-0413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013892720
289 rdf:type schema:CreativeWork
290 https://doi.org/10.2337/dc12-2006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050389695
291 rdf:type schema:CreativeWork
292 https://doi.org/10.2337/dc12-2454 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002457907
293 rdf:type schema:CreativeWork
294 https://doi.org/10.2337/dc12-2462 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026984704
295 rdf:type schema:CreativeWork
296 https://doi.org/10.2337/dc12-2709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004232638
297 rdf:type schema:CreativeWork
298 https://doi.org/10.2337/dc12-s011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026975709
299 rdf:type schema:CreativeWork
300 https://doi.org/10.2337/dc13-0520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042419212
301 rdf:type schema:CreativeWork
302 https://doi.org/10.2337/diabetes.52.1.102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052696912
303 rdf:type schema:CreativeWork
304 https://doi.org/10.2337/diacare.23.9.1272 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006261908
305 rdf:type schema:CreativeWork
306 https://doi.org/10.2337/diacare.28.5.1083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053076188
307 rdf:type schema:CreativeWork
308 https://doi.org/10.2337/diacare.28.5.1092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007868854
309 rdf:type schema:CreativeWork
310 https://doi.org/10.4158/ep13176.cs schema:sameAs https://app.dimensions.ai/details/publication/pub.1011456704
311 rdf:type schema:CreativeWork
312 https://doi.org/10.5414/cp201361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072833982
313 rdf:type schema:CreativeWork
314 https://doi.org/10.7326/0003-4819-154-2-201101180-00300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073712032
315 rdf:type schema:CreativeWork
316 https://www.grid.ac/institutes/grid.273109.e schema:alternateName Cardiff and Vale University Health Board
317 schema:name University Hospital Llandough, Llandough, Cardiff, UK
318 rdf:type schema:Organization
319 https://www.grid.ac/institutes/grid.411414.5 schema:alternateName Antwerp University Hospital
320 schema:name Antwerp University Hospital, Edegem-Antwerp, Belgium
321 rdf:type schema:Organization
322 https://www.grid.ac/institutes/grid.414336.7 schema:alternateName Marseille Public University Hospital System
323 schema:name Sainte-Marguerite University Hospital, Marseille, France
324 rdf:type schema:Organization
325 https://www.grid.ac/institutes/grid.417555.7 schema:alternateName Sanofi (United States)
326 schema:name Sanofi, Bridgewater, NJ, USA
327 rdf:type schema:Organization
328 https://www.grid.ac/institutes/grid.4488.0 schema:alternateName TU Dresden
329 schema:name GWT-TUD, Study Centre Prof. Hanefeld, Dresden Technical University, Fiedlerstr. 34, 01307, Dresden, Germany
330 rdf:type schema:Organization
331 https://www.grid.ac/institutes/grid.492821.4 schema:alternateName LMC Diabetes & Endocrinology (Canada)
332 schema:name LMC Diabetes and Endocrinology, Toronto, Canada
333 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...